Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on reposted from The Lancet Hematology on LinkedIn:
”Check out this podcast from The Lancet Haematology to help you plan your ASH25, we give an overview of key novelties to look out for across various sessions!”
Qutoing The Lancet Hematology‘s post:
”Are you planning to attend ASH25 in Orlando?
There’s no better way to get a sneak peek at the exciting content than hearing experts share their insights firsthand.
In our latest special episode of In Conversation With, a roundtable of leading classical and malignant haematology thought leaders — Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda Balari — preview the most anticipated ASH25 sessions and their expectations for the upcoming congress.
They discuss practical implications for clinicians, researchers, and trainees, and offer takeaways to maximise your time at the meeting.
Key areas covered:
- Thalassaemia and sickle cell disease
- Thrombosis and bleeding disorders
- Multiple myeloma
- Myeloid neoplasms
- Cellular therapies, stem-cell transplantation, and lymphoma
Tune in now; search The Lancet Haematology wherever you get your podcasts.
If you’re attending ASH25 or following from afar, please share with colleagues preparing for the meeting!
Don’t forget to hit subscribe to stay ahead with the latest in haematology!”
Find the full coverage of ASH25 in Hemostasis Today.
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026